Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia-ko ikertzaileekin lankidetzan egindako argitalpenak (69)

2024

  1. Allelic variants of the estrogen receptor genes and frailty phenotype in postmenopausal women

    Climacteric, Vol. 27, Núm. 3, pp. 314-320

  2. Alterations in the volume and shape of the basal ganglia and thalamus in schizophrenia with auditory hallucinations

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 131

  3. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

    Science advances, Vol. 10, Núm. 41, pp. eadn6525

  4. Association between anxiety and frailty in postmenopausal women

    Gynecological Endocrinology, Vol. 40, Núm. 1

  5. Decoding Nucleotide Repeat Expansion Diseases: Novel Insights from Drosophila melanogaster Studies

    International Journal of Molecular Sciences, Vol. 25, Núm. 21

  6. Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome

    Neurochemistry International, Vol. 174

  7. Light deficiency in Apoe−/−mice increases atheroma plaque size and vulnerability by modulating local immunity

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 4

  8. Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model

    Biomedical Journal, Vol. 47, Núm. 4

  9. Physical activity to reduce the burden of frailty after menopause: effectiveness and adherence rate of a resource saving exercise plan

    Menopause, Vol. 31, Núm. 7, pp. 634-640

  10. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research, Vol. 267, pp. 534-545

  11. Shared vulnerability and sex-dependent polygenic burden in psychotic disorders

    European Neuropsychopharmacology, Vol. 86, pp. 49-54

  12. Taurine activates the AKT-mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy

    Disease models & mechanisms, Vol. 17, Núm. 4

  13. The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes

    Cancers, Vol. 16, Núm. 11

  14. Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models

    Biological Research, Vol. 57, Núm. 1

  15. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice

    Journal of Nutritional Biochemistry, Vol. 134

2023

  1. BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice

    Pharmaceutics, Vol. 15, Núm. 4

  2. Both reduced ovarian reserve and severe semen alterations are overrepresented in couples seeking assisted reproductive technology treatment for the first time: a cross-sectional study

    Reproductive Health, Vol. 20, Núm. 1

  3. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction

    Frontiers in Endocrinology, Vol. 14

  4. CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2

    Molecular Therapy - Nucleic Acids, Vol. 31, pp. 324-338

  5. Common genetic variants contribute to heritability of age at onset of schizophrenia

    Translational Psychiatry, Vol. 13, Núm. 1